Endocrinology

  • Hyperpigmentation as a clue to Addison disease
    Yusuke Hirota, MD, PhD and Takaya Matsushita, MD, PhD
    Cleveland Clinic Journal of Medicine September 2022, 89 (9) 498-499; DOI: https://doi.org/10.3949/ccjm.89a.21082

    The 66-year-old woman presented with fatigue, loss of appetite, and hyperpigmentation of the tongue, soft palate, buccal mucosa, lower lip, fingers, and nail beds.

  • Primary and secondary prevention of atherosclerotic cardiovascular disease: A case-based approach
    CME article
    Essa H. Hariri, MD, MS, Mazen M. Al Hammoud, BS, Steven E. Nissen, MD and Donald F. Hammer, MD
    Cleveland Clinic Journal of Medicine September 2022, 89 (9) 513-522; DOI: https://doi.org/10.3949/ccjm.89a.21103

    The authors present commonly encountered clinical scenarios that pose challenges in decision-making in primary and secondary prevention.

  • Xanthomas: Differentiating atherogenic from nonatherogenic
    Vy Mai, MD and Hossein Akhondi, MD
    Cleveland Clinic Journal of Medicine August 2022, 89 (8) 429-431; DOI: https://doi.org/10.3949/ccjm.89a.21088

    The patient had tendinous xanthomas on the dorsal joints of the hand and eruptive xanthomas on the buttock, as well as xanthoma striatum palmare on the volar aspect of the hand.

  • The role of GLP-1 receptor agonists in managing type 2 diabetes
    The role of GLP-1 receptor agonists in managing type 2 diabetes
    CME article
    Noura Nachawi, MD, Pratibha PR Rao, MD, MPH and Vinni Makin, MBBS, MD, FACE
    Cleveland Clinic Journal of Medicine August 2022, 89 (8) 457-464; DOI: https://doi.org/10.3949/ccjm.89a.21110

    A review of the evidence regarding the benefits and adverse effects of GLP-1 receptor agonists in patients with type 2 diabetes mellitus or obesity.

  • Acute anxiety and tachycardia in a hospitalized 59-year-old woman
    Andres I. Applewhite, MD, Fernando F. Stancampiano, MD, Dana M. Harris, MD, Victor Bernet, MD, Joseph G. Cernigliaro, MD and Jose R. Valery, MD
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 383-391; DOI: https://doi.org/10.3949/ccjm.89a.21002

    The patient presented with neck pain, painful swallowing, headache, and fever. She had contracted lymphoproliferative disease after liver transplant. She had stage 3 chronic kidney disease.

  • Spotty skin pigmentation in Carney complex
    Azusa Sano, MD, Yosuke Ono, MD, PhD, Naoya Fujita, MD and Yuji Tanaka, MD, PhD
    Cleveland Clinic Journal of Medicine June 2022, 89 (6) 307-308; DOI: https://doi.org/10.3949/ccjm.89a.21069

    Characteristic skin findings and their locations can indicate underlying hereditary lentiginosis syndromes.

  • Treating anemia: It’s not just the EPO
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 174-175; DOI: https://doi.org/10.3949/ccjm.89b.04022

    Long-term effects of treatment with the new oral inhibitors of prolyl hydroxylase will need to be carefully monitored, as prolyl hydroxylase is a key structural component of diverse proteins.

  • Oral hyperpigmentation with weakness and salt-craving
    Joseph Zhou, MD and S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 180-181; DOI: https://doi.org/10.3949/ccjm.89a.21036

    The patient’s primary care physician had attributed the hyperpigmentation on the lower lip and inner cheek to pen ink.

  • The devil is in the details: Approach to refractory hypokalemia
    CME article
    Carmen Elena Cervantes, MD, Karthik Meiyappan Udayappan, MD and Duvuru Geetha, MBBS, MD
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 182-188; DOI: https://doi.org/10.3949/ccjm.89a.21013

    The authors illustrate a stepwise approach to the evaluation of acid-base disturbances.

  • Glycemic targets in the ICU: A look back, and ahead
    Keren Zhou, MD
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 189-190; DOI: https://doi.org/10.3949/ccjm.89a.21127

    Much work is still needed to understand the nuances of glycemic targets in critically ill patients, and to learn how to take advantage of evolving technology to improve glycemic control.

Pages